AscellaHealth

AscellaHealth, strategically headquartered in Berwyn, Pennsylvania, maintains a formidable presence across the United States and Europe, marking its territory as a pivotal entity in the specialty pharmacy and healthcare services sectors. This organization prides itself on delivering an expansive range of personalized, technologically advanced specialty pharmaceutical and healthcare management services. These services are meticulously designed to address the unique needs of an extensive clientele, including payers, providers, life sciences companies, and patients, particularly those grappling with complex chronic conditions or rare diseases necessitating specialized medications and advanced therapies. Dea Belazi, the CEO and Co-founder of AscellaHealth, plays a crucial role in shaping the company's strategic direction and operational execution. His dual expertise as a registered pharmacist and an accomplished business leader enables him to craft and enhance AscellaHealth's portfolio of services. These services are essential for assisting pharmaceutical manufacturers in the successful launch and commercialization of specialized and rare disease medications, aiming to improve patient outcomes significantly. Bill Oldham, alongside Belazi, co-founded AscellaHealth and contributes as the Chairman and President. His extensive background in fintech has dramatically influenced the company's strategic initiatives, particularly in the pharmacy benefit management (PBM) sector, propelling the company to a leadership position within the industry. Oldham's visionary leadership has driven the company to achieve a significant 1556% growth in revenue over four years through strategic expansions and acquisitions. His notable leadership and fiscal management have garnered him prestigious accolades, including being named the Philadelphia Business Journal's 2022 CFO of the Year and a member of the Philadelphia Titan 100 for successive years.